The Singapore Family Physician
Back to issue
Vol 47 No. 3 - Osteoporosis: A Growing Primary Care Concern
Patients Risk Stratification in the Management of Osteoporosis: the Latest International Guidelines
The Singapore Family Physician
Vol 47
No 3
- Osteoporosis: A Growing Primary Care Concern
8
- 16
1 March 2021
0377-5305
Assessment of risk of a fragility fracture is a vital step a physician needs to undertake in every patient suspected of osteoporosis, as this will influence the decisions on whether to treat with a pharmacological agent, with which drug, and for how long. After risk stratification, patients deemed Very High-Risk should be considered for an anabolic agent, or if this is not feasible, a parenteral anti-resorptive. High- Risk or Moderate-Risk patients may be considered for oral bisphosphonates.